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permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.SUMMARYDifferentiated cells can be reprogrammed into induced pluripotent stem cells (iPSCs) after overexpressing four transcription factors, of
which Oct4 is essential. To elucidate the role of Oct4 during reprogramming, we investigated the immediate transcriptional response
to inducible Oct4 overexpression in various somatic murine cell types using microarray analysis. By downregulating somatic-specific
genes, Oct4 induction influenced each transcriptional program in a unique manner. A significant upregulation of pluripotent markers
could not be detected. Therefore, OCT4 facilitates reprogramming by interfering with the somatic transcriptional network rather than
by directly initiating a pluripotent gene-expression program. Finally,Oct4 overexpression upregulated the geneMgarp in all the analyzed
cell types. Strikingly, Mgarp expression decreases during the first steps of reprogramming due to a KLF4-dependent inhibition. At later
stages, OCT4 counteracts the repressive activity of KLF4, thereby enhancing Mgarp expression. We show that this temporal expression
pattern is crucial for the efficient generation of iPSCs.INTRODUCTION
Somatic cells can be reprogrammed into induced pluripo-
tent stem cells (iPSCs) after the forced expression of three
or four transcription factors: Oct4, Sox2, Klf4, and option-
ally,Myc (Nakagawa et al., 2008; Takahashi and Yamanaka,
2006). Oct4 is indispensable for establishing pluripotency
in the embryo (Nichols et al., 1998) and for maintaining
pluripotency in mouse embryonic stem cells (ESCs) (Niwa
et al., 2000). Under physiological conditions, the OCT4
protein needs to interact with SOX2 for activating most
of its target genes and for maintaining the self-renewal of
ESCs (Boyer et al., 2005; Reme´nyi et al., 2003; Rodda
et al., 2005). Nevertheless, overexpression of Oct4 can
rescue ESC self-renewal in the absence of Sox2 (Masui
et al., 2007), indicating that Sox2 is not essential for sup-
porting pluripotency. In addition, Sox2 can be replaced
by other Sox factors or by transforming growth factor b
inhibitors in the reprogramming of somatic cells into iPSCs
(Ichida et al., 2009; Nakagawa et al., 2008). Likewise, Klf4 is
dispensable for maintaining ESC self-renewal (Jiang et al.,
2008) and for inducing pluripotency (Nakagawa et al.,
2008), as Klf2 and Klf5 can replace Klf4 in both functions.
In addition, Esrrb can also substitute Klf4 in iPSCs gene-
ration (Feng et al., 2009). Therefore, Oct4 is the only
transcription factor in the conventional reprogramming
cocktail that is essential for pluripotency.
To date, the role of OCT4 in reprogramming has been
studied only in the context of its interaction with SOX2
(Buganim et al., 2012; Hansson et al., 2012; Polo et al.,Stem C2012; Sridharan et al., 2009; Stadtfeld et al., 2008). As exog-
enous Sox2 is not required for inducing pluripotency
(Ichida et al., 2009; Maherali and Hochedlinger, 2009),
we decided to investigate the specific effect of OCT4 alone
in the first steps of reprogramming. To circumvent the
inevitable heterogeneity generated by viral factor delivery,
we established a set of different somatic cell types from
tetracycline-inducible Oct4 transgenic mice. This approach
facilitates the study of rare events in cell populations that
simultaneously activate Oct4. Finally, we performed global
gene-expression profile analyses to identify the early tran-
scriptional changes caused by ectopic Oct4 expression in
somatic cells. Overall, our study provides insights into
the specific OCT4-dependent events that promote the in-
duction of pluripotency.RESULTS
Generation and Characterization of Different
Oct4-Inducible Somatic Cell Types
To analyze the immediate transcriptional response trig-
gered by Oct4 overexpression in somatic cells, we derived
mouse embryonic fibroblasts (MEFs), neural stem cells
(NSCs), and bone marrow cells (BMCs) from mice con-
taining both a tetracycline transactivator and a tetracy-
cline-inducible Oct4 transgene and termed these cells
tetracycline-operon-controlled Oct4-expression cassette
(TO)-MEFs, TO-NSCs (cell line number 1), and TO-BMCs,
respectively. In addition, we established an NSC line fromell Reports j Vol. 2 j 351–365 j March 11, 2014 j ª2014 The Authors 351
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(CtrlNSC) as a control to detect nonspecific tetracycline
transactivator activities unrelated to OCT4. Finally, non-
transgenic MEFs were also used as a control to identify
effects caused by the tetracycline treatment itself (CtrlMEF)
(Figure 1A).
Using immunocytochemistry, we assessed the level of
OCT4 protein expression after 24 hr of doxycycline induc-
tion in each generated cell type. We counted 98% of
TO-MEFs to be positive for OCT4 staining, with intensity
levels comparable to those observed in ESCs (Figure 1B).
In contrast, only 40% of TO-BMCs and 10% of TO-NSCs
(number 1) exhibited strongly induced OCT4 expression.
Interestingly, 40% of TO-NSCs (number 1) became OCT4
positive after treatment with 5-azacytidine (Figure 1B),
suggesting the presence of a DNA-methylation-based
mechanism for transgene silencing in this cell type. For
this reason, we decided to exclude TO-NSC line number
1 fromour study. Instead, we transduced CtrlNSC with a len-
tiviral vector coding for the same TO cassette that is present
in the other cell types (Stadtfeld et al., 2008; Figure 1A).
This newly generated TO-NSC line (number 2) could effi-
ciently induce OCT4 expression in 98% of the cells after
doxycycline treatment and was thus the only TO-NSC
line used in the subsequent experiments (Figure 1B).
Next, the induction of exogenous Oct4 expression was
analyzed in a time course manner by quantitative RT-PCR
(qRT-PCR). After 6 hr, all cell types exhibited ESC-like
Oct4 transcript levels (Figure 1C). Furthermore, immuno-
blotting confirmed OCT4 expression at the protein level
(Figure 1D). We also surveyed the onset of OCT4 trans-
lation in more detail by immunocytochemistry. OCT4
protein emerged as early as 2 to 3 hr after induction and
reached saturation levels after approximately 6 hr (Fig-
ure 1E). Consistentwith previous observations (Hochedlin-
ger et al., 2005; Wang et al., 2011), in-vitro-cultured
somatic cells showed impaired proliferation after Oct4
overexpression (Figure S1 available online).
To assess whether the Oct4 induction levels are sufficient
for iPSC generation, we transduced the different cell types
with retroviral vectors coding for Sox2, Klf4, andMyc. After
inducing Oct4, we generated Oct4-GFP-positive, ESC-like
colonies from all somatic cell types and established clonal,
doxycycline-independent cell lines (Figure 2A). The reprog-
ramming efficiency and kinetics using the inducible Oct4
transgene were similar to those achieved using viral deliv-
ery of Oct4 (data not shown). The generated iPSC lines
stained positive for the pluripotency markers alkaline
phosphatase (ALP; Figure 2A), NANOG, and SSEA-1 (Fig-
ure 2B). As ESCs, iPSCs exhibited unmethylated Oct4 and
Nanog promoters (Figure 2C). Moreover, all iPSC lines
were capable of differentiating into all three germ layers
in vitro and in vivo after embryoid body formation (Fig-352 Stem Cell Reports j Vol. 2 j 351–365 j March 11, 2014 j ª2014 The Authure 2D) and blastocyst injection (Figure 2E), respectively.
Finally, germline contribution was demonstrated by the
presence ofOct4-GFP-positive germ cells in the fetal gonads
(Figure 2E). In summary, we have derived three different
somatic cell types that can efficiently induce Oct4 expres-
sion to levels supporting iPSC generation.
Oct4 Induction Affects the Gene-Expression Profile in
a Cell-type-Specific Manner
To identify the OCT4 targets during the first steps of
reprogramming, we collected samples of the different
Oct4-inducible cells and controls at 0, 6, 12, and 24 hr
after Oct4 induction with doxycycline treatment. Global
gene-expression profiles were then recorded by microarray
analysis. Upregulation of Oct4 expression was clearly
confirmed in all inducible cell types, but not in the controls
(Figure 3A). The two corresponding Oct4-detecting array
probes were not further considered in the subsequent
analyses. Induced TO-MEF and TO-NSC cultures, which
express the Oct4 transgene most uniformly, exhibited a
stronger transcriptional response than TO-BMCs. CtrlMEF
cells showed hardly any transcriptional response to the
doxycycline treatment. However, differential expression
of some genes was observed in the tetracycline-transactiva-
tor-containing CtrlNSC cells, suggesting the need for a
more-refined analytic strategy that could precisely distin-
guish OCT4-dependent from OCT4-independent effects
(Figure 3A). Therefore, we assigned a score to each probe
in each cell type. This score is based primarily on the total
signal change within 24 hr but also incorporates additional
parameters such as expression changes in the controls, the
dynamic behavior throughout the time course, and the
absolute signal intensity as an indicator for noise artifacts.
Probes with a score higher than 1 or lower than 1 were
defined as up- or downregulated, respectively (for details,
see Experimental Procedures and Figure S2). Surprisingly,
the genes that were most strongly upregulated differed
greatly from one cell type to another, indicating that the
immediate targets of OCT4 are unique to each cell type
(Figure 3B). Interestingly, fewer than 50% of the genes
that were upregulated by OCT4 in the different cell types
are expressed in ESCs (Figure 3B) and only a small subset
(<4%) of these ESC-expressed genes is ESC-specific, i.e.,
not expressed in any other cell type examined (Table S1).
The genes that were most strongly downregulated by
OCT4 expression differed among the cell types, and
many genes were specific to each cell type (Figure 3C). In
fact, 21.0%, 12.4%, and 70.1% of genes downregulated in
TO-MEFs, TO-NSCs, and TO-BMCs, respectively, were not
expressed in any other cell type in our data set, suggesting
a possible early effect of Oct4 expression in the disruption
of the respective somatic regulatory program. Surprisingly,
many downregulated genes are also highly expressed inors
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Figure 1. Generation and Characterization of Tetracycline-Inducible Oct4 Cells and Controls Used for Dynamic Global Gene-
Expression Analysis
(A) Fibroblasts (TO-MEFs), neural stem cells (TO-NSCs number 1), and bone marrow cells (TO-BMCs) contain a tetracycline transactivator, a
tetracycline-operon Oct4-expression cassette, and an Oct4-GFP reporter. NSCs with a tetracycline transactivator and an Oct4-GFP reporter
but lacking a tetracycline-operon Oct4 cassette (CtrlNSC) served as a control for nonspecific transactivator activity. Wild-type C57BL/6
fibroblasts were used as a control for drug response artifacts (CtrlMEF). TO-NSCs number 2 were generated after transducing CtrlNSC with a
lentiviral vector coding for a tetracycline-operon Oct4. Transcriptional effects of Oct4 expression were investigated by microarray analysis
at different time points after doxycycline induction.
(B) Immunological staining for OCT4 protein (red) in the different cell types after 24 hr of doxycycline induction. Nuclei were counter-
stained with Hoechst (blue). The scale bars represent 50 mm.
(C) Expression of Oct4 mRNA (qRT-PCR), normalized to an embryonic stem cell (ESC) control. The error bars represent SE of calculations
based on DCt values obtained from two different housekeeping genes: Gapdh and Actb (n = 1).
(D) OCT4 protein immunoblot of induced and uninduced samples. GAPDH was used as a loading control.
(E) OCT4 protein translation time course after doxycycline induction. OCT4 protein and nuclei are shown in red and blue, respectively. The
scale bars represent 50 mm.
Abbreviations: dpc, days postcoitum; dpp, days postpartum; Dox, doxycycline; AzaC, 5-azacytidine; TO, tetracycline-inducible. See also
Figure S1 as well as Tables S5 and S6.
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Figure 2. Characterization of iPSCs Generated from Tetracycline-Inducible Oct4 Cells
(A) Clonal induced pluripotent stem cell (iPSC) lines generated by tetracycline-induced Oct4 expression in combination with virally
delivered Sox2, Klf4, andMyc. Phase-contrast overlay with Oct4-GFP reporter fluorescence and ALP staining. The scale bars represent 50 mm.
(B) Immunological stainings for NANOG and SSEA-1 (red), overlaid with nuclear Hoechst staining (blue). The scale bars represent 50 mm.
(C) DNA methylation of Oct4 and Nanog promoters in iPSCs and controls. Empty and full circles represent unmethylated and methylated
CpG cytosine residues, respectively.
(D) Immunocytochemistry for specific marker proteins (red) showed in vitro differentiation of iPSC clones into all three germ layers. Nuclei
were counterstained with Hoechst (blue). The scale bars represent 50 mm.
(E) PCR genotyping for the GFP transgene demonstrated that iPSCs could contribute to organs representative of all germ layers in 14.5 dpc
chimeric embryos. Germline contribution was proven by the presence of Oct4-GFP-positive cells in the fetal gonads. The black scale bars
represent 5 mm. The white scale bars represent 250 mm.
Abbreviations: TUBB3, b-III-tubulin (ectoderm; neurons); ACTA2, a-II-actin (mesoderm; smooth muscle cells); SOX17, SRY-box-
containing 17 (definitive endoderm); br, brain; he, heart; li, liver. See also Tables S5 and S6.
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Competition between OCT4 and KLF4 in ReprogrammingESCs (55.4%, 79.1%, and 16.6% in TO-MEFs, TO-NSCs, and
TO-BMCs, respectively; Figure 3C). To further investigate
whether the OCT4 target genes reflect common cellular
processes, we performed gene ontology analyses (Tables
S2–S4). The few statistically enriched ontology terms ap-
peared to be remarkably unique for each cell type. Strik-
ingly, no ontology terms for upregulated genes were found,
with the exception of the unexpected term ‘‘neuron projec-
tion’’ in TO-MEFs. In contrast, the downregulated genes
were enriched for ontologies related to the specific cell
type.Moreover, TO-NSCs showed downregulation of genes
related to the ‘‘mitotic cell cycle’’ and other similar terms.
Several of these genes were also downregulated in induced
TO-MEFs. This result correlates with the observed prolifer-
ation impairment caused by Oct4 overexpression in both
cell types (Figure S1).
An unsupervised hierarchical clustering (Figure S3A) and
a principal-component analysis (PCA) (Figure 3D) showed
all the time points for a specific cell type clustering
together, indicating that the OCT4-induced changes in
global gene expression were rather small, compared to
the overall differences distinguishing one cell type from
the other. However, TO-MEFs and TO-NSCs after 24 hr of
Oct4 induction were more different from their uninduced
counterparts than were CtrlMEF and CtrNSC cells, respec-
tively. We also compared the numbers of differentially ex-
pressed genes between each pair of samples (Figure S3B).
Importantly, none of the cell types became more similar
to ESCs upon Oct4 induction, as assessed by gene expres-
sion. PCA confirmed that the transcriptional program of
the different cell types shifted away from that of ESCs
and revealed that the direction of gene-expression changes
was unique to each cell type (Figure 3D). Overall, these
results suggest that, early in reprogramming, Oct4 ex-
pression interferes with the somatic cell transcriptional
network in a cell-type-specific manner, but does not
directly induce a pluripotent cell fate or a gene-expression
signature common to all cell types examined.
Mgarp Is One of the Few Genes that Are Commonly
Upregulated in All Cell Types
To identify common targets of OCT4,we directly compared
the sets of up- and downregulated genes for each individual
cell type but only detected a few overlaps (Figures 4A and
4B). From a total of 1,441 upregulated probes, 102 (7.1%)
were upregulated in two different cell types, and only
four genes (0.3%), namely Parm1, Mgarp, Slc24a3, and
Tmem53, were commonly upregulated in all three different
cell types (Figure 4A). The intersections within the downre-
gulated genes were even smaller, as 107 (6.7%) of 1,587
probes were downregulated in two different cell types.
Not a single gene was commonly downregulated in TO-
NSCs, TO-MEFs, and TO-BMCs (Figure 4B). The vast major-Stem City of both up- and downregulated genes thus represent
unique effects of Oct4 expression that occur only in a spe-
cific cellular environment. Of note, the nonuniform induc-
tion pattern observed in TO-BMCsmight contribute to this
finding, as uninduced cells will dilute themeasurable gene-
expression changes. However, TO-MEFs and TO-NSCs,
which exhibit homogeneous Oct4 induction, have in com-
mon only 6.5% of their up- and downregulated genes. We
also identified 71 genes that were oppositely regulated by
Oct4 expression, i.e., they were upregulated in at least one
cell type while being downregulated in at least another
(Figure 4C). Furthermore, 83.2% of the commonly down-
regulated genes are expressed in ESCs. In contrast, only
58.7% of the commonly upregulated genes are expressed
in ESCs and as few as 5.8% are ESC-specific (Figure 4C).
Surprisingly, these ESC-specific genes do not include any
key pluripotency markers (Table S1). Finally, we selected
the four commonly upregulated as well as two commonly
downregulated and two oppositely regulated genes (Fig-
ure 5A) and validated their dynamic gene-expression
changes using qRT-PCR (Figure 5B). Our results indicate
that ectopic Oct4 expression does not activate a common
transcriptional program in different somatic cell environ-
ments and show that only four genes are commonly upre-
gulated in all the cell types examined.
OCT4-Dependent Upregulation ofMgarp Is
Counteracted by KLF4 to Ensure Successful
Reprogramming
We then investigated Parm1 andMgarp, the two genesmost
strongly upregulated by OCT4 in all the three cell types
examined. Overexpression and knockdown of Parm1 had
no effect on iPSC generation (data not shown), and there
is no indication of an association between this gene and
pluripotency or reprogramming. However, Mgarp (mito-
chondria-localized glutamic acid rich protein) is present
in both ESCs and epiblast stem cells. Mgarp expression
was not detected in early primordial germ cells but was
induced to ESC-like levels in male germ cells at 13.5 days
postcoitum (dpc) and maintained in spermatogonial stem
cells after birth. In contrast, female germ cells did not ex-
press Mgarp (Figure S4). Furthermore, Mgarp is transcribed
in several organs such as ovary, testis, the visual system,
and the brain (Kinouchi et al., 2006; Li et al., 2009; Matsu-
moto et al., 2009; Qi et al., 2011).
To investigate a possible role ofMgarp in reprogramming,
we generated a set of viral vectors to increase or decrease the
Mgarp expression level in a constitutive or tetracycline-
inducible manner (Figure S5). MEFs, NSCs, and BMCs
bearing an Oct4-GFP reporter transgene were transduced
with viruses coding for mouse Oct4, Sox2, Klf4, and Myc
plus Mgarp or small hairpin RNA against Mgarp (shMgarp).
Three weeks later, we assessed for ALP activity (Figure 6A)ell Reports j Vol. 2 j 351–365 j March 11, 2014 j ª2014 The Authors 355
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Competition between OCT4 and KLF4 in Reprogrammingand counted the number of Oct4-GFP-positive iPSC col-
onies (Figure 6B). Strikingly,Mgarp constitutive overexpres-
sion caused a dramatic decline in colony numbers to fewer
than 10% of the respective control (Figure 6B). This indi-
cates that, although Mgarp is expressed in pluripotent
stem cells and upregulated by the key reprogramming fac-
tor OCT4, high Mgarp levels are detrimental to the reprog-
ramming process. Unexpectedly, constitutive knockdown
ofMgarp did not have the opposite effect—but it also signif-
icantly reduced the number of iPSC colonies in all the
analyzed cell types (Figure 6B). To better understand this
ambivalent role of Mgarp in reprogramming, we analyzed
the effect of the reprogramming factors OCT4, SOX2,
KLF4, and MYC, individually and in combination, on the
transcriptional activation of Mgarp. Consistent with our
previous observations, OCT4 strongly and stably induced
the upregulation of Mgarp expression. SOX2 and MYC
did not have any effect on Mgarp expression. In contrast,
KLF4 strongly inhibited the transcription of Mgarp (Fig-
ure 6C). A very interesting pattern of expression was
observed after the combined overexpression of Oct4 and
Klf4 alone or together with Sox2 and Myc. In fact, Mgarp
expression levels first decreased until day 6 after transduc-
tion but then started to increase. This temporal expression
pattern was maintained at lowered levels in the presence
of two different constitutive shMgarp constructs and was
completely disrupted by constitutiveMgarp overexpression
(Figure 6C). Based on these results, we hypothesized that
continual high levels of Mgarp (Oct4, Sox2, Klf4, and Myc
[OSKM] + Mgarp) as well as constant low levels of
Mgarp (OSKM + shMgarp) interfere with the initial
Mgarp downregulation and the subsequent Mgarp up-
regulation steps induced by KLF4 and OCT4, respectively
(Figure 6C). To directly test this hypothesis, we transduced
MEFs with Oct4, Sox2, Klf4, and Myc plus tetracycline-
inducible vectors forMgarp overexpression or knockdown.
The expression or inhibition was induced at different
time points (Figure 6D). Mgarp overexpression within the
first 3 days of the reprogramming process significantly
reduced colony numbers, as it interfered with theFigure 3. Global Gene-Expression Analysis after Induction of Oct
(A) Scatter plots comparing expression profile before and after Oct4 o
increased and decreased intensity upon Oct4 induction are depicted
pressed probes (<2-fold difference). The two Oct4 probes are highligh
(B) Identification of the OCT4-induced upregulated genes. Heatmaps
presenting the highest score value. The expression levels in an ESC c
(C) Identification of OCT4-induced downregulated genes. Heatmaps
presenting the lowest score.
(D) Principal-component analysis (PCA) of global transcriptome data. T
variability among the individual samples are shown. The numbers in
component.
See also Figures S2, S3, and Tables S1–S4.
Stem Cinitial step in which the level of Mgarp needs to decrease.
Consistently, Mgarp induction at later stages did not affect
the reprogramming efficiency. As expected, Mgarp knock-
down, which interferes with late steps, was detrimental
for the induction of pluripotency independently of the
time of onset (Figure 6D). Therefore, our results demon-
strate that a specific two-step time course of Mgarp expres-
sion is required for reprogramming and that disturbing
either of the two steps impairs iPSC generation.
Next, we investigated whether OCT4 and KLF4 regulate
Mgarp by directly binding to regulatory regions within its
genomic locus. OCT4 protein has previously been shown
to bind near the Mgarp gene in mouse ESCs using a
chromatin immunoprecipitation (ChIP)-chip approach
(Mathur et al., 2008). Indeed, we identified a putative
OCT4 binding motif (Chen et al., 2008) in the first intron
ofMgarp (Figure 7A). Furthermore, theMgarp promoter fea-
tures a sequence with a high similarity to the consensus
KLF4 bindingmotif (Chen et al., 2008; Figure 7A). To assess
whether OCT4 and KLF4 bind to the Mgarp locus, we
designed a set of primers that span approximately 5 kb
up- and downstream of the Mgarp transcription start site
(Figure 7A) and performed ChIP-quantitative PCR (qPCR)
in MEFs overexpressing Oct4 or Klf4. We detected an
enrichment of both OCT4 (Figure 7B) and KLF4 (Figure 7C)
in proximity of the identified candidate binding sites.
Interspecies genome comparisons further supported the
notion that Mgarp is a direct target gene of OCT4 (Fig-
ure 7D) and KLF4 (Figure 7E), as both binding motifs are
well conserved across a variety of mammalian species.
The MGARP protein is localized in the mitochondria
and was reported to alter mitochondrial distribution and
transport (Li et al., 2009). Interestingly, a crucial step in
reprogramming is the transition from a somatic-oxidative
to a pluripotent-glycolytic metabolism by remodeling the
mitochondrial network (Folmes et al., 2011; Kelly et al.,
2013). To test whether the role ofMgarp in reprogramming
is related to mitochondria, we overexpressed Mgarp in
MEFs. However, we did not observe any effects on mito-
chondria numbers or respiratory activity (Figure S6).4 Alone
verexpression for each cell type examined (log2 scale). Probes with
in red and green, respectively. The blue area contains equally ex-
ted.
show the temporal changes in signal intensities for the ten genes
ontrol are shown for comparison.
show the temporal changes in signal intensities for the ten genes
he three principal components that contribute most strongly to the
side the circles denote hours after Oct4 induction. P.C., principal
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Figure 4. Shared and Unique Oct4 Targets
(A) Venn diagram depicting overlaps of upregulated gene sets among the different cell types after Oct4 induction.
(B) Venn diagram depicting overlaps of downregulated gene sets.
(C) Common up, genes with highest scores that are upregulated in at least two different cell types. Common down, genes with lowest scores
that are downregulated in at least two different cell types. Contrary, genes that are oppositely expressed among at least two different cell
types. Unique up, genes with highest scores that are upregulated in only one cell type. Unique down, genes with lowest scores that are
downregulated in only one cell type.
358 Stem Cell Reports j Vol. 2 j 351–365 j March 11, 2014 j ª2014 The Authors
Stem Cell Reports
Competition between OCT4 and KLF4 in Reprogramming
AB
1 2 3 4 5 6 7 8 9 10 11 12
signal intensity  (log2 scale)
CtrlNSC
CtrlMEF
0 126 24
ESC0 24
TO-MEF
TO-NSC
TO-BMC
Kank4
6.3 6.0 4.1 3.8
8.0 6.7 5.8 5.6
3.3 5.1 4.1 4.5
4.3 4.7 6.7
5.2 5.7
CtrlNSC
CtrlMEF
6.3 5.5 8.2 11.5
3.8 3.9 5.7 6.4
4.5 5.7 7.4 6.7
7.0 5.9 8.0
4.2 4.4
0 126 24
ESC0 24
TO-MEF
TO-NSC
TO-BMC
Mgarp
CtrlNSC
CtrlMEF
0 126 24
ESC0 24
TO-MEF
TO-NSC
TO-BMC
Gap43
6.1 8.3 10.0 10.9
8.8 8.4 7.3 5.0
1.6 2.2 2.1 2.5
9.0 9.0 3.7
8.7 8.9
CtrlNSC
CtrlMEF
0 126 24
ESC0 24
TO-MEF
TO-NSC
TO-BMC
Slc24a3
8.2 8.3 10.1 11.2
10.5 9.8 10.7 12.3
7.1 7.6 7.7 8.2
11.8 11.1 4.2
9.1 9.0
CtrlNSC
CtrlMEF
0 126 24
ESC0 24
TO-MEF
TO-NSC
TO-BMC
Adora2b
9.1 7.5 6.9 6.4
7.7 3.6 3.0 2.9
7.9 8.1 7.8 8.1
7.1 6.8 6.5
8.9 8.7
CtrlNSC
CtrlMEF
0 126 24
ESC0 24
TO-MEF
TO-NSC
TO-BMC
Parm1
8.0 9.7 11.4 12.0
5.9 5.5 7.2 8.3
2.7 6.8 8.2 8.3
6.0 7.0 6.5
8.6 8.4
CtrlNSC
CtrlMEF
0 126 24
ESC0 24
TO-MEF
TO-NSC
TO-BMC
Gadd45g
9.8 8.3 6.7 6.8
8.2 9.8 9.3   10.2
8.1 8.3 7.7 7.5
10.3 9.9 7.2
10.0 9.4
CtrlNSC
CtrlMEF
0 126 24
ESC0 24
TO-MEF
TO-NSC
TO-BMC
Tmem53
8.6 8.7 9.0 9.9
6.4 6.3 7.9 7.9
4.9 5.4 5.9 6.2
7.0 6.9 6.1
8.7 8.4
TO-MEF TO-BMCTO-NSC CtrlNSC CtrlMEF
0.01
0.1
1
10
100
0 6 12 24
egnahc
dlof
hours after induction
Gadd45g
0.01
0.1
1
10
100
0 6 12 24
egnahc
dlof
hours after induction
0.01
0.1
1
10
100
0 6 12 24
egnahc
dlof
hours after induction
Kank4
0.01
0.1
1
10
100
0 6 12 24
egnahc
dlof
hours after induction
Gap43
0.01
0.1
1
10
100
0 6 12 24
hours after induction
egnahc
dlof
Mgarp
egnahc
dlof
0.01
0.1
1
10
100
0 6 12 24
hours after induction
Slc24a3
0.01
0.1
1
10
100
0 6 12 24
egnahc
dlof
hours after induction
Tmem53
egnahc
dlof
0.01
0.1
1
10
100
0 6 12 24
hours after induction
Parm1
Adora2b
m
ic
ro
ar
ra
y
qR
T-
P
C
R
Figure 5. Validation of OCT4 Target Genes
Identified in the Microarray Analysis
(A) The only four commonly upregulated
(Parm1, Mgarp, Slc24a3, and Tmem53) and
two examples of commonly downregulated
(Adora2b and Kank4) as well as contrarily
regulated genes (Gap43 and Gadd45 g) were
chosen. Microarray signal intensities for all
samples and controls at different time
points after induction are shown as heat-
maps. Arrows indicate in which cell types
the criteria for up- or downregulation were
fulfilled.
(B) Dynamic gene-expression analysis of
the same genes using qRT-PCR, normalized
to the respective uninduced cells. The error
bars represent SE of calculations based on
DCt values obtained from two different
housekeeping genes: Gapdh and Actb (n = 1).
See also Table S5.
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Competition between OCT4 and KLF4 in ReprogrammingFinally, Mgarp, which is expressed in ESCs and required
to establish pluripotency, does not play a role in ESC self--
renewal, as Mgarp knockdown did not affect ESC
morphology or proliferation (Figure S7).
In summary, our data suggest that the initial decrease in
Mgarp expression is a consequence of direct inhibition by
KLF4 and that the subsequent increase inMgarp expression
is a direct effect of activation by OCT4. Most importantly,
iPSC generation is severely impaired by interference with
either the initialMgarp decrease (OSKM+Mgarp) or the sub-Stem Csequent Mgarp increase (OSKM + shMgarp). Therefore, the
counteracting regulatory activities of OCT4 and KLF4
ensure the specific Mgarp time pattern of expression that
is essential to induce pluripotency.DISCUSSION
In this study, we derived different Oct4-inducible somatic
cell types to identify early transcriptional events inducedell Reports j Vol. 2 j 351–365 j March 11, 2014 j ª2014 The Authors 359
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Figure 6. Different Mgarp Expression Levels Required at Early and Late Stages during Reprogramming of Somatic Cells into iPSCs
Are Competitively Regulated by OCT4 and KLF4
(A) Reprogramming of MEFs, NSCs, and BMCs into iPSCs using different factor combinations. Representative wells were stained for ALP
activity (red) on day 21 after infection.
(B) Oct4-GFP-positive iPSC colonies were counted on day 21 after infection with different factor combinations. The error bars represent SD
of the mean (biological replicates, n = 5). p values refer to a two-tailed, unpaired Student’s t test: *p < 103; **p < 104; ***p < 105.
(C) Monitoring of Mgarp expression levels (qRT-PCR) during a 15-day period after infection of MEFs with different combinations of genes,
normalized to ESCs. The error bars represent SD of the mean (biological replicates, n = 4).
(D) Oct4-GFP-positive iPSC generated after infection of MEFs with four factors plus tetracycline-inducible (Tet-) vectors for Mgarp
overexpression or knockdown. The expression or inhibition was induced at different time points, as indicated. The error bars represent SD
of the mean (biological replicates, n = 5). p values refer to a two-tailed, unpaired Student’s t test: *p < 103; **p < 104; ***p < 105; n.s.,
not significant (p > 0.1). Abbreviations: shRNA, small hairpin RNA; OSKM, Oct4, Sox2, Klf4, and Myc.
See also Figures S4–S7 and Table S5.
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Competition between OCT4 and KLF4 in Reprogrammingby the exogenous OCT4 protein during cellular reprog-
ramming. Our global gene-expression analyses revealed
that OCT4 does not induce expression of pluripotency-
related genes in somatic cells during the first 24 hr after
its overexpression. On the contrary, many ESC-expressed
genes are downregulated by OCT4 in somatic cells. In
addition, our data demonstrate that OCT4 activates and
inhibits different genes in a cell-type-dependent manner.
The OCT4-upregulated genes are highly variable from one
cell type to another and do not present any common
ontological pattern. Some genes were upregulated in
one cell type while being downregulated in other cell
types. Thus, our results suggest that OCT4 alone can360 Stem Cell Reports j Vol. 2 j 351–365 j March 11, 2014 j ª2014 The Authinduce a general perturbation in the somatic cell tran-
scriptional network at the early steps of reprogramming,
partially through the downregulation of cell-type-specific
genes. Indeed, OCT4 has been reported to not only
activate pluripotent genes but also repress developmental
regulators in ESCs (Boyer et al., 2005; Rodda et al., 2005).
However, the sequences to which OCT4 is bound in
ESCs do not maintain the same accessibility in different
types of somatic cells (Koche et al., 2011; Soufi et al.,
2012). Therefore, different cell-type-dependent chro-
matin signatures could explain the differences in gene
expression between MEFs, NSCs, and BMCs after Oct4
induction.ors
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Figure 7. OCT4 and KLF4 Bind to the
Mgarp Genomic Locus
(A) Position of 13 ChIP-qPCR amplicons (a–
m) spanning approximately 5 kb up- and
downstream of the Mgarp transcriptional
start site. Blue bars indicate the covered
regions, as estimated by the average size of
crosslinked DNA fragments. The asterisk
indicates position of a putative OCT4 bind-
ing motif within the first intron of Mgarp;
double asterisks indicate position of a pu-
tative KLF4 binding motif within the Mgarp
promoter.
(B) ChIP-qPCR analysis after a-OCT4 immu-
noprecipitation of crosslinked DNA isolated
from Oct4-overexpressing MEFs. Relative
occupancies to a negative control region
(neg. ctrl., rDNA-28S). a–m, amplicons as
specified in (A); pos. ctrl., OCT4 binding site
positive control within regulatory region of
Oct4.
(C) ChIP-qPCR analysis after a-KLF4 immu-
noprecipitation of crosslinked DNA isolated
from Klf4-overexpressing MEFs. pos. ctrl.,
KLF4 binding site positive control within
regulatory region of Cdh1. The error bars in
(B) and (C) represent SEM (technical repli-
cates, n = 3).
(D and E) Conservation of the identified
OCT4 (D) and KLF4 (E) motif in different
mammalian genomes.
See also Tables S5 and S6.
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Competition between OCT4 and KLF4 in ReprogrammingFibroblasts can be directly reprogrammed into neurons
(Vierbuchen et al., 2010), cardiomyocytes (Ieda et al.,
2010), and NSCs (Han et al., 2012) using tissue-specific
combinations of transcription factors. However, the plurip-
otent reprogramming cocktail of Oct4, Sox2, Klf4, and Myc
can also convert fibroblasts into cardiomyocytes (Efe et al.,
2011) and NSCs (Kim et al., 2011; Thier et al., 2012) under
suitable culture conditions. In addition, the overexpression
of only Oct4 has been reported to reprogram fibroblasts
toward the hematopoietic lineage (Szabo et al., 2010). In
these studies, the overexpression ofOct4 alone or in combi-
nation with other transcription factors is thought to force
the cells into an unstable and plastic intermediate (Orkin
and Hochedlinger, 2011) that can be pushed toward the
desired final cell type by specific environmental cues. WeStem Cspeculate that the initial stochastic phase of the reprogram-
ming process (Buganim et al., 2012; Hanna et al., 2009)
involves a transient transcriptionally unstable state that
may be a prerequisite to the hierarchical events that take
place during the late steps of reprogramming (Buganim
et al., 2012). In addition, the reprogramming transgenes
are usually expressed at higher levels during reprogram-
ming than their corresponding endogenous counterparts
in ESCs. These nonphysiological conditions may promote
nonspecific binding to low-affinity binding sites and
contribute to transcriptional chaos and instability. Our
data suggest that Oct4 overexpression at early stages of
reprogramming plays a role in the initiation of such an
unstable intermediate through the inhibition of the so-
matic cell-type-specific program rather than through theell Reports j Vol. 2 j 351–365 j March 11, 2014 j ª2014 The Authors 361
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Competition between OCT4 and KLF4 in Reprogrammingactivation of the pluripotent transcriptional network. Our
results are consistent with previous four factor studies
showing that fibroblast-specific genes are downregulated
at early stages and that pluripotency-related genes are not
upregulated until the late stages of reprogramming (Bram-
brink et al., 2008; Stadtfeld et al., 2008). AlthoughMYCwas
suggested to be the reprogramming factor primarily
responsible for suppressing the cell-type-specific program
(Sridharan et al., 2009), our data show that OCT4 alone
can also inhibit somatic transcriptional networks. Finally,
current available data suggest that OCT4, SOX2, and
KLF4 act synergistically, as OCT4 heterodimerizes with
SOX2 in order to maintain ESC self-renewal (Boyer et al.,
2005) and OCT4, SOX2, and KLF4 co-occupy the pro-
moters of many reprogramming-related genes (Soufi
et al., 2012; Sridharan et al., 2009). In contrast, we show
that OCT4 alone is able to initiate certain steps in reprog-
ramming, such as the activation of Mgarp, and that OCT4
and KLF4 play an antagonistic role on Mgarp transcrip-
tional regulation.
Whereas each cell type exhibited a unique pattern of up-
and downregulated genes, four genes were upregulated by
OCT4 in all examined somatic cell types, includingMgarp.
Our results show that the process of inducing de novo
pluripotency does not simply consist of the activation of
ESC-specific genes to the levels present in ESCs. Instead,
some genes such as Mgarp need to be first downregulated
and subsequently upregulated during the reprogramming
process. We have elucidated the mechanism underlying
this counterintuitive temporal expression pattern. In fact,
KLF4 alone completely abolishesMgarp expressionwhereas
OCT4 alone induces high levels ofMgarp. This competitive
interplay ensures that appropriate expression levels of
Mgarp aremaintainedatdifferent timepoints,whichappear
to be crucial for a successful reprogramming process, as
either the permanent inhibition or the premature activa-
tion of Mgarp prevents the efficient generation of iPSCs.
To our knowledge,Mgarp is the first gene described to date
upon which KLF4 and OCT4 exhibit antagonistic effects.
The mechanism that regulates the switch from KLF4- to
OCT4-regulatedMgarp expression remains to be identified.
In summary, we have dissected the specific role that
OCT4 plays during the first steps of reprogramming inde-
pendently of the other reprogramming factors. We have
shown that OCT4 does not require SOX2 to interfere
with cell-type-specific gene-expression profiles or to
initiate an unstable transcriptional state that facilitates re-
programming. Finally, we have discovered a mechanism
by which OCT4 and KLF4 compete to differentially regu-
late Mgarp expression, resulting in distinct expression
levels at different stages of reprogramming. Therefore,
our study sheds new light on the function of OCT4 in
the reprogramming process.362 Stem Cell Reports j Vol. 2 j 351–365 j March 11, 2014 j ª2014 The AuthEXPERIMENTAL PROCEDURES
Cell Derivation and Culture
Different somatic cell types were derived from transgenic mice
containing a tetracycline-inducible transactivator (rtTA-M2), a
TO (Hochedlinger et al., 2005), and a GOF18 Oct4-GFP transgene
in which the GFP is driven by 18 kb of the Oct4 regulatory region
(Yoshimizu et al., 1999). In addition, a control cell line was gener-
ated from transgenic mice, comprising a tetracycline-inducible
transactivator (irtTA–VP16–GBD; Anastassiadis et al., 2002) plus
an OG2 Oct4-GFP reporter transgene (Yoshimizu et al., 1999) but
lacking a TO cassette. MEFs and NSCs were derived from 14.5
dpc embryos and cultured as previously described (Conti et al.,
2005). BMCs were isolated from 6-week-old mice after flushing
the femora and tibiae and plated onto dishes with a combined
coating of gelatin (PAA Laboratories), laminin (Santa Cruz Biotech-
nology), and poly-L-lysine (Sigma), and cultivated in Dulbecco’s
modified Eagle’s medium (DMEM) Low Glucose (Gibco) with
10% fetal bovine serum, 100 U/ml penicillin, 100 mg/ml strepto-
mycin, and 2 mM/l glutamine (all PAA). The transgenic Oct4
was induced by either 6 mg/ml doxycycline (Sigma) or 2 mg/ml
doxycycline plus 107 M dexamethasone (Sigma), depending on
the respectively contained tetracycline transactivator. 5-azacyti-
dine (10 nM; Sigma) was applied as indicated. Generation, culture,
and differentiation of ESCs and iPSCswere performed as previously
described (Tiemann et al., 2011). Animal handling was in accor-
dance with the Max Planck Institute animal protection guidelines
and the German animal protection laws.
Viral Vectors
Production and transduction of viral vectors were performed as
reported (Han et al., 2010). Retroviral pMXs vectors encoding
for Oct4, Sox2, Klf4, and Myc (Takahashi and Yamanaka, 2006)
aswell as the lentiviral vectors TetOP-CMV-Oct4 andM2-rtTA tetra-
cycline-transactivator (Stadtfeld et al., 2008) were purchased from
Addgene (plasmids numbers 13366, 13367, 13370, 13375, 19766,
and 20342).Mgarp cDNAwas amplified and cloned into the pMXs
and TetOP-CMV backbones. shRNA constructs targeting Mgarp
were cloned into the lentiviral vectors pLVTHM (Wiznerowicz
and Trono, 2003; Addgene number 12247) and Tet-pLKO-puro
(Wee et al., 2008; Addgene number 21915). A Klf4-2a-tomato over-
expression cassette was also cloned into the pLVTHM backbone
(Han et al., 2011).
iPSC Characterization
Immunocytochemistry, immunoblotting, ALP staining, methyl-
ation analysis, and blastocyst injection were performed as pre-
viously described (Han et al., 2011, 2013; Tiemann et al., 2011).
Relative transcript expression levels were calculated based on
the DDCt method after normalization to Gapdh and Actb house-
keeping controls (Kim et al., 2008). Primers and antibodies are
listed in Tables S5 and S6, respectively.
Measurement of Mitochondrial Activity and Copy
Number
Mitochondria were stained for 30 min with 30 nM tetramethylr-
hodamine methyl ester (Invitrogen) and quantified on a BDors
Stem Cell Reports
Competition between OCT4 and KLF4 in ReprogrammingFACSAria II flow cytometer (Becton Dickinson). Copy numbers
of mitochondrial DNA were assessed by quantitative PCR (Kelly
et al., 2013).ChIP
MEFs overexpressing Oct4 (TO-MEFs after doxycycline treatment)
or Klf4 (MEFs sorted for tomato expression after transduction
with LVTHM-Klf4-2a-tomato) were used for ChIP. Cell cultures
were crosslinked with 1% formaldehyde for 10 min at room tem-
perature and sonicated using a Bioruptor device (Diagenode).
Chromatin was immunoprecipitated with the corresponding
antibodies, and the precipitated DNA was analyzed by qRT-
PCR. Primers and antibodies are listed in Tables S5 and S6,
respectively.Microarray Gene-Expression Analysis
Sample preparation and analysis was performed as previously
described (Tapia et al., 2012). Score values representing up- and
downregulated genes were calculated from the processed raw
data as follows (Figure S2). Signal changes for each probe and
each cell type were calculated by subtraction of the logarithmic
values between 0 hr and 24 hr (Dtotal). To reduce the impact of
high relative changes in noisy background expression, the signal
change was set to zero if the signal intensity never reached a
threshold of six. Next, two correction parameters were introduced.
The first parameter compensates for signal changes that do not
show a gradual tendency throughout the time course. To this
end, subtraction values between 6 and 0 hr, 12 and 6 hr, and 24
and 12 hr were calculated only for those signal intensities greater
than six. If any of these intermediate steps presents a sign (positive
or negative) that differs from that of the overall trend, this value is
subtracted from the Dtotal value. The second correction parameter
compensates for signal changes that are observed not only in the
sample cell type but also in one or both controls. In this case, the
subtraction value between 24 and 0 hr of the control cell line
that presents the most similar behavior to the studied sample
was subtracted from Dtotal. Finally, the sign of the score after sub-
tracting the two correction parameters cannot become different
from the original sign of Dtotal. Probes with a score higher than 1
or lower than 1 were considered up- or downregulated, respec-
tively, which corresponds to more than a 2-fold total change in
expression.
Gene ontology analyses were performed using the Functional
Annotation tool of the DAVID bioinformatics database (Huang
da et al., 2009).ACCESSION NUMBERS
The Gene Expression Omnibus database (http://www.ncbi.nlm.
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